null
Loading... Please wait...
FREE SHIPPING on All Unbranded Items LEARN MORE
Print This Page

Comprehensive Management of High Risk Cardiovascular Patients

List Price: $87.99
SKU:
9781420066777
Quantity:
Minimum Purchase
25 unit(s)
  • Availability: Confirm prior to ordering
  • Branding: minimum 50 pieces (add’l costs below)
  • Check Freight Rates (branded products only)

Branding Options (v), Availability & Lead Times

  • 1-Color Imprint: $2.00 ea.
  • Promo-Page Insert: $2.50 ea. (full-color printed, single-sided page)
  • Belly-Band Wrap: $2.50 ea. (full-color printed)
  • Set-Up Charge: $45 per decoration
FULL DETAILS
  • Availability: Product availability changes daily, so please confirm your quantity is available prior to placing an order.
  • Branded Products: allow 10 business days from proof approval for production. Branding options may be limited or unavailable based on product design or cover artwork.
  • Unbranded Products: allow 3-5 business days for shipping. All Unbranded items receive FREE ground shipping in the US. Inquire for international shipping.
  • RETURNS/CANCELLATIONS: All orders, branded or unbranded, are NON-CANCELLABLE and NON-RETURNABLE once a purchase order has been received.
  • Product Details

    Author:
    Antonio M. Gotto, Peter P. Toth
    Format:
    Paperback
    Pages:
    770
    Publisher:
    CRC Press (July 9, 2007)
    Language:
    English
    Audience:
    Professional and scholarly
    ISBN-13:
    9781420066777
    Weight:
    47.25oz
    Dimensions:
    7" x 10"
    File:
    TAYLORFRANCIS-TayFran_260415045620654-20260415.xml
    Folder:
    TAYLORFRANCIS
    List Price:
    $87.99
    Country of Origin:
    United States
    Case Pack:
    10
    As low as:
    $83.59
    Publisher Identifier:
    P-CRC
    Discount Code:
    H
    Pub Discount:
    30
    Imprint:
    CRC Press
  • Overview

    Designed as a resource for the busy, practicing clinician, the approach in this book is evidence-based but practical. Reinforced by case studies, the book discusses standards of care and challenging management issues. The authors discuss pharmacotherapeutic choices in light of findings from clinical trials, elements of care unique to women and people of different racial and ethnic groups, lifestyle modifications, and the risks and benefits of specific therapies. Moreover, they encourage primary care providers to get more involved in treating such disorders as atherosclerotic disease, congestive heart failure, severe hypertension, complex dyslipidemias, and chronic renal disease, among others.